NMDA-receptor encephalitis in Denmark from 2009 to 2019: a national cohort study.

Mette Scheller NissenMaren Synnøve ØrvikAnna Christine NilssonMatias RydingMagnus LydolphMorten Blaabjerg

Published in: Journal of neurology (2021)

The incidence of NMDARE in Denmark is currently 0.17/100,000 persons per year, and has increased since 2009. NMDARE patients in Denmark display a higher median age, lower female:male ratio, a less frequent tumor association and need for ICU admission. Maintenance therapy did not reduce relapse rate. Poor outcome was seen with higher age, likely related to underlying etiology.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
emergency department
risk factors
stem cells
mesenchymal stem cells
acute respiratory distress syndrome